Enhanced anti-HCV activity of interferon alpha 17 subtype

BACKGROUND: Pegylated interferon alpha 2 (a or b) plus ribavirin is the most effective treatment of chronic hepatitis C but a large proportion of patients do not respond to therapy. So, it is interesting to improve the treatment efficacy. Interferon alpha is a type I interferon composed of 12 differ...

Descripción completa

Detalles Bibliográficos
Autores principales: Dubois, Aurelie, François, Catherine, Descamps, Veronique, Fournier, Carole, Wychowski, Czeslaw, Dubuisson, Jean, Castelain, Sandrine, Duverlie, Gilles
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2697159/
https://www.ncbi.nlm.nih.gov/pubmed/19493343
http://dx.doi.org/10.1186/1743-422X-6-70

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2697159/
https://www.ncbi.nlm.nih.gov/pubmed/19493343
http://dx.doi.org/10.1186/1743-422X-6-70

Ejemplares similares